Maternal care for anti-D [Rh] antibodies
ICD-10 O36.01 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies.
Maternal care for anti-D [Rh] antibodies is a critical aspect of obstetric management, particularly in pregnancies where the mother is Rh-negative and has developed antibodies against Rh-positive blood. This condition can lead to hemolytic disease of the fetus and newborn (HDFN), which may result in fetal anemia, hydrops fetalis, or even fetal demise if not properly managed. Care for these patients involves regular monitoring of fetal well-being through ultrasound assessments, Doppler studies to evaluate blood flow, and potentially intrauterine transfusions if severe anemia is detected. Additionally, maternal care may include administration of Rh immunoglobulin (RhoGAM) to prevent the formation of further antibodies in future pregnancies. The management of anti-D antibodies requires a multidisciplinary approach, often involving obstetricians, maternal-fetal medicine specialists, and pediatricians to ensure optimal outcomes for both mother and fetus.
Detailed records of maternal blood type, antibody screening results, and any interventions performed.
Management of an Rh-negative mother with a history of anti-D antibodies during pregnancy.
Ensure that all fetal assessments and maternal treatments are documented to support coding.
Comprehensive documentation of high-risk assessments, including ultrasound findings and fetal monitoring.
Monitoring and managing a fetus with suspected anemia due to maternal anti-D antibodies.
Focus on the implications of fetal distress and growth restriction in the context of Rh incompatibility.
Used when intrauterine transfusions are performed for fetal anemia due to maternal anti-D antibodies.
Document the indication for transfusion and maternal consent.
Ensure coordination with maternal-fetal medicine specialists.
Coding O36.01 is crucial for identifying pregnancies at risk for complications due to maternal anti-D antibodies. Accurate coding ensures appropriate management and monitoring, which can significantly impact maternal and fetal outcomes.
